Showing results (11-20 of 328) with videos related to
Sort By:
Pageof 33
La Revue Du Praticien|December 5, 2018
[LDL-cholesterol hypothesis:the lower is trully better]Bertrand Cariou, Sarra SmatiExpert Opinion on Investigational Drugs|November 10, 2015
Sotagliflozin as a potential treatment for type 2 diabetes mellitusBertrand Cariou, Bernard CharbonnelMedecine Sciences : M/S|April 24, 2010
[Cholesterol metabolism and beta-cell function]Cédric Langhi, Bertrand CariouMed (New York, N.Y.)|August 9, 2025
Obicetrapib and CETP inhibition: An exception to the rule?Bertrand Cariou, Philippe MoulinCurrent Opinion in Lipidology|March 20, 2018
Poststatin era in atherosclerosis management: lessons from epidemiologic and genetic studiesLaurent Yvan-Charvet, Bertrand CariouTrends in Biochemical Sciences|August 2, 2008
PCSK9 and LDL cholesterol: unravelling the target to design the bulletPhilippe Costet, Michel Krempf, Bertrand CariouEuropean Journal of Endocrinology|October 25, 2013
Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolismBruno Vergès, Thomas Walter, Bertrand CariouBiochemical Pharmacology|December 17, 2011
DPP-4 inhibitors in the treatment of type 2 diabetesHélène Duez, Bertrand Cariou, Bart StaelsTrends in Endocrinology and Metabolism: TEM|April 20, 2012
Thiazolidinediones and PPARγ agonists: time for a reassessmentBertrand Cariou, Bernard Charbonnel, Bart StaelsAnnales D'Endocrinologie|October 20, 2012
New avenues for the pharmacological management of type 2 diabetes: an updateThomas Cuny, Bruno Guerci, Bertrand CariouPageof 33